Sichuan Kelun Pharmaceutical: Announcement of Resolutions of the First Meeting of the Eighth Board of Supervisors
Sichuan Kelun Pharmaceutical: Announcement of the resolution of the first meeting of the 8th Board of Directors
Sichuan Kelun Pharmaceutical: May 13, 2024 Investor Relations Activity Schedule
Sichuan Kelun Pharmaceutical: Announcement of Resolutions of the 37th Meeting of the Seventh Board of Directors
Sichuan Kelun Pharmaceutical: Announcement on holding the 2023 online results briefing
Sichuan Kelun Pharmaceutical: Investor Relations Activity Schedule for April 25, 2024
Colon Pharmaceutical: Continued Supervision and Inspection Opinions and Continued Supervision Summary Report of Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the spin-off of the subsidiary Yili Chuanning Biotechnology Co., Ltd. from Sichuan Colon Pharmaceutical Co., Ltd. to GEM listing
Colon Pharmaceuticals: Independent Director Nominee's Statement and Commitment (Ren Shichi)
Colon Pharmaceuticals: Announcement of Supervisory Committee Resolutions
Colon Pharmaceuticals: Announcement on renewing the company's 2024 accounting firm
Colon Pharmaceuticals: Annual Verification Report on the Use of Raised Funds
Colon Pharmaceuticals: Annual Special Audit Report on Related Party Capital Occupation
Colon Pharmaceuticals: Deliberation Opinions at the 3rd Special Meeting of Independent Directors in 2024
Colon Pharmaceutical: Changjiang Securities Underwriting and Sponsorship Co., Ltd. on the 2023 regular on-site inspection report of Sichuan Kelun Pharmaceutical Co., Ltd.
Colon Pharmaceutical: Changjiang Securities Underwriting and Sponsorship Co., Ltd.'s inspection opinions on the transfer of partnership shares and related transactions by some senior managers of Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceuticals: Independent Directors' Self-Inspection Report on the 2023 Independence Situation
Colon Pharmaceuticals: Independent Director Nominee Statement and Commitment (Gao Jinbo)
Colon Pharmaceuticals: Special instructions on the use of annual funds raised
Colon Pharmaceuticals: 2023 Annual Audit Report
Colon Pharmaceutical: Changjiang Securities Underwriting and Sponsorship Co., Ltd. special inspection report on the storage and use of funds raised by Sichuan Colon Pharmaceutical Co., Ltd. in 2023
No Data